Ticker Report HC Wainwright downgraded shares of Adicet Bio (NASDAQ:ACET - Free Report) from a buy rating to a neutral rating in a research report released on Wednesday, Marketbeat reports. Several other research...\n more…
Ticker Report Adicet Bio (NASDAQ:ACET - Get Free Report) was downgraded by investment analysts at StockNews.com from a "hold" rating to a "sell" rating in a research report issued on Tuesday. Several other...\n more…
SeekingAlpha.com: All News Adicet Bio (ACET) stock slips as company reallocates resources to focus its lead asset on ADI-001 for autoimmune conditions. Read more here.\n more…
Seeking Alpha - Healthcare Adicet Bio narrows focus on lead asset...\n more…